Yuki Kitano

17PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersPolymers and plasticsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 06, 2026
Statin Use Is Associated With Improved Survival But Not Progression-Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab.

|Jul 03, 2026
Preoperative Total Iron-Binding Capacity Is a Novel Surrogate Marker of Short- and Long-Term Outcomes After Liver Resection for Hepatocellular Carcinoma.

|Mar 09, 2026
Response to "Letter to the Editor Regarding Prognostic Impact of Hepatectomy Versus Radiofrequency Ablation for Non-Small Hepatocellular Carcinoma (2-3 cm): A Case-Matched Study".

Yuki Kitano, Hiromitsu Hayashi, Takumi Tanizaki

|Nov 25, 2025
High γ-H2AX Predicts Clinical Benefit From Platinum-Based Chemotherapy (mFOLFIRINOX) at Recurrence After Pancreatic Cancer Resection.

Takashi Matsumoto, Zhao Liu, Kosuke Kanemitsu

|Nov 07, 2025
Prognostic Impact of Hepatectomy Versus Radiofrequency Ablation for Non-Small Hepatocellular Carcinoma (2-3 cm): A Case-Matched Study.

Yuki Kitano, Hiromitsu Hayashi, Takumi Tanizaki

|May 17, 2025
Round ligament coverage with polyglycol acid mesh and fibrin glue on pancreatic stump may decrease postoperative pancreatic fistula in distal pancreatectomy.

Yuki Adachi, Hirohisa Okabe, Hiromitsu Hayashi

Pageof 3

Frequent Collaborators

4 joint publications

Masaaki Iwatsuki

3 joint publications

Hiromitsu Hayashi

3 joint publications

Takashi Matsumoto

3 joint publications

Shigeki Nakagawa